Shine-On BioMedical Co.,Ltd. (6926.TWO)
TWD 66.0
(-1.35%)
TWD 66.0
(-1.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 9.52 Million | - | - | - |
| Cost of Revenue | 2.85 Million | - | - | - |
| Gross Profit | 6.66 Million | - | - | - |
| Operating Expenses | 69.35 Million | 18.61 Million | 8.62 Million | - |
| Selling, General and Administrative Expenses | 15.1 Million | 11.71 Million | 2.62 Million | - |
| Research and Development Expenses | 54.24 Million | 6.89 Million | 5.99 Million | - |
| Other Expenses | - | -11.36 Million | - | - |
| Cost and Expenses | 72.2 Million | 18.61 Million | 8.62 Million | - |
| Operating Income | -62.68 Million | -21.79 Million | -8.41 Million | - |
| Interest Expense | 13 Thousand | 26 Thousand | 16 Thousand | - |
| Income Tax Expense | 2.22 Million | -2.27 Million | - | - |
| Earnings before Tax | -34.93 Million | -21.81 Million | -8.43 Million | - |
| Net Income | -37.16 Million | -19.54 Million | -8.43 Million | - |
| Earnings Per Share Basic | -0.75 | -0.43 | -0.46 | - |
| Earnings Per Share Diluted | -0.75 | -0.43 | -0.46 | - |
| Weighted Average Shares Outstanding | 49.8 Million | 45.41 Million | 18.32 Million | 43 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.8 Million | 45.41 Million | 18.47 Million | 43 Million |
| Gross Margin | 0.70 | - | - | - |
| EBIT Margin | -3.47 | - | - | - |
| Profit Margin | -3.90 | - | - | - |
| EBITDA | -33 Million | -20.16 Million | -7.77 Million | - |
| Earnings Before Tax Margin | -6.58 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 4.76 Million | 9.52 Million | 4.76 Million | - |
| Cost of Revenue | 1.1 Million | - | 1.42 Million | 2.85 Million | 1.42 Million | - |
| Gross Profit | -1.1 Million | - | 3.33 Million | 6.66 Million | 3.33 Million | - |
| Operating Expenses | 27.14 Million | 27 Million | 19.5 Million | 69.35 Million | 19.5 Million | 11.31 Million |
| Selling, General and Administrative Expenses | 3.48 Million | 3.48 Million | 4.21 Million | - | 4.21 Million | 3.33 Million |
| Research and Development Expenses | 23.66 Million | 23.66 Million | 17.15 Million | - | 17.15 Million | 9.96 Million |
| Other Expenses | - | - | - | 7.69 Million | - | - |
| Cost and Expenses | 27.14 Million | 27 Million | 20.93 Million | 72.2 Million | 20.93 Million | 11.31 Million |
| Operating Income | -27.14 Million | -27.14 Million | -18.04 Million | -34.92 Million | -18.04 Million | -13.29 Million |
| Interest Expense | - | - | - | 13 Thousand | - | - |
| Income Tax Expense | 60.5 Thousand | 60.5 Thousand | 488.5 Thousand | 2.22 Million | 488.5 Thousand | 626 Thousand |
| Earnings before Tax | -23.16 Million | -23.16 Million | -11.69 Million | -34.93 Million | -11.69 Million | -5.76 Million |
| Net Income | -23.22 Million | -23.22 Million | -12.18 Million | -37.16 Million | -12.18 Million | -6.39 Million |
| Earnings Per Share Basic | -0.47 | -0.47 | -0.25 | - | -0.25 | -0.13 |
| Earnings Per Share Diluted | -0.47 | -0.47 | -0.24 | - | -0.24 | -0.13 |
| Weighted Average Shares Outstanding | 49.8 Million | 49.95 Million | 49.74 Million | 49.55 Million | 49.74 Million | 49.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.8 Million | 49.95 Million | 49.8 Million | 49.8 Million | 49.8 Million | 49.8 Million |
| Gross Margin | - | - | 0.70 | 0.70 | 0.70 | - |
| EBIT Margin | - | - | -3.75 | - | -3.75 | - |
| Profit Margin | - | - | -2.56 | -3.90 | -2.56 | - |
| EBITDA | -26.96 Million | -26.59 Million | -17.86 Million | - | -17.86 Million | -13.12 Million |
| Earnings Before Tax Margin | - | - | -3.79 | -3.67 | -3.79 | - |
2898
688013
0090
002819
4741
6708